|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
| ||||||||||||||||||||
Files in this Data Supplement:
Fig. S1. Percentage of bromodeoxyuridine (BrdU)-positive cells in cells overexpressing VRK1 or VRK3. HeLa cells transfected with Flag-tagged VRK1 and VRK3 were treated with 10 μM BrdU for the indicated times and then fixed. Immunofluorescence of VRK (detected with anti-Flag for the primary antibody and FITC-conjugated secondary antibody) and BrdU (detected with anti-BrdU and TRITC-conjugated secondary antibody) was observed under fluorescence microscopy and cells expressing VRK alone and both VRK and BrdU were counted. The percentage of BrdU-positive cells in Flag-positive cells from more than 100 cells was plotted.
Fig. S2. Myc binding on the VRK1 promoter in the presence or absence of VRK1 siRNA. ChIP assay measuring Myc binding to conserved Myc-binding sites in the VRK1 promoter of HeLa cells transfected with pHA-Myc.
| ||||||||||||||||||||